StonvexLoading…
StonvexCore line items from NSC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.00B | $12.18B | $9.21B | $6.10B |
Operating Income | $877.00M | $4.36B | $3.42B | $2.32B |
Net Income | $547.00M | $2.87B | $2.23B | $768.00M |
EPS (Diluted) | $2.43 | $12.75 | $9.88 | $6.72 |
Total Assets | $45.11B | $45.24B | $44.58B | $44.16B |
Total Liabilities | $29.31B | $29.69B | $29.44B | $29.37B |
Cash & Equivalents | $1.34B | $1.53B | $1.42B | $1.30B |
Free Cash Flow OCF − CapEx | $-38.00M | $2.16B | $1.82B | $1.10B |
Shares Outstanding | 224.59M | 224.42M | 224.39M | 224.61M |